Stem Cell Vaccine Carries Potential as Mesothelioma Treatment

Research & Clinical Trials

Written by Tim Povtak

Reading Time: 3 mins
Publication Date: 03/06/2018
Fact Checked
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Reviewed is the nation’s most trusted mesothelioma resource

The Mesothelioma Center at has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.

Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.

More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.

About The Mesothelioma Center at

  • Assisting mesothelioma patients and their loved ones since 2006.
  • Helps more than 50% of mesothelioma patients diagnosed annually in the U.S.
  • A+ rating from the Better Business Bureau.
  • 5-star reviewed mesothelioma and support organization.
Learn More About Us


My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family.
Mesothelioma patient’s daughter
  • Google Review Rating
  • BBB Review Rating

How to Cite’s Article


Povtak, T. (2021, September 27). Stem Cell Vaccine Carries Potential as Mesothelioma Treatment. Retrieved June 6, 2023, from


Povtak, Tim. "Stem Cell Vaccine Carries Potential as Mesothelioma Treatment.", 27 Sep 2021,


Povtak, Tim. "Stem Cell Vaccine Carries Potential as Mesothelioma Treatment." Last modified September 27, 2021.

stem cells

Researchers at the Stanford University School of Medicine believe a patient-specific stem cell vaccine could become part of mesothelioma treatment — and possibly prevention — in the future.

The belief stems from their recent study that demonstrated a consistent immunologic response with genetically-altered stem cells in laboratory mice carrying particular cancer cells.

“This could potentially play a role for a large group of — if not all — cancers,” Dr. Joseph Wu, director of the Stanford Cardiovascular Institute, told “We envision it potentially being used as a vaccine or adjuvant treatment for mesothelioma.”

The study involved induced pluripotent stem cells (IPS), which are cells taken from the blood or skin and genetically reprogramed. This allows the cells to attack or prevent cancerous tumors when mixed with a generic immune-stimulating agent.

Vaccine Shows Anti-Tumor Response

The study tested mice infected separately with breast cancer, melanoma and mesothelioma cells. The anti-tumor response rate was similar in all three types of cancer.

“This is significant for future cancer therapies, that we now have a surrogate cell that can provide the immune system with a large amount of cancer-related antigens,” Wu said. “Based on preliminary studies, the effectiveness of our vaccine is not limited to one cancer.”

IPS cells typically are used in regenerative medicine, often to repair damage from trauma or disease. This latest study explored their use as immune system facilitators to stop the development of tumors.

Researchers found the implanted tumors grew steadily in mice in the study control group. Conversely, tumors shrank in 70 percent of mice treated with the vaccine with IPS cells and the generic adjuvant.

The study is especially significant for mesothelioma, the rare cancer with no definitive cure and no FDA-approved second-line treatment options.

Even with multidisciplinary treatment at specialty centers, the two-year survival rate is less than 30 percent.

Different Clinical Uses

Wu said he can envision two types of strategy for the anti-cancer vaccine with IPS cells:

  • Prophylactic Treatment: The vaccine could be used as a preventative measure, given to high-risk patients to bolster the immune system at an age when they are most vulnerable. People with long-term occupational exposure to asbestos — the primary cause of mesothelioma — could be targeted. The hope would be preventing the cancer entirely, or at least delay the onset of the cancer.
  • Adjuvant Treatment: The vaccine might be used following or during standard treatment such as surgery, chemotherapy or radiation. The vaccine could reactivate a weakened immune system to target any tumor cells left behind after first-line therapy or target the tumors cells when they are most vulnerable.

“These cells, as a component of our proposed vaccine, have strong immunogenic properties that provoke a system-wide, cancer-specific immune response,” lead author Dr. Nigel Kooreman wrote in his study. “We believe this approach has exciting clinical potential.”

Researchers believe the next step will be testing their methods in a laboratory setting with human cancers and clinical trials.

“Although much research remains to be done, the concept itself is pretty simple,” Wu told the Stanford News Center. “We would take your blood, make IPS cells and then inject the cells to prevent future cancers. I’m excited about future possibilities.”

blue medical health symbol
Connect with a Mesothelioma Doctor
Find a Top Specialist Near You